Drug Trial Radar · NCT03348254
Antibiotic Prophylaxis in Primary Joint Arthroplasty of the Hip and Knee.
Last checked: Nov 19, 2026Latest source record: Mar 27, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
242,179
Actual
Start
Apr 2016
Primary completion
Jan 2019
Study completion Mar 2019
Sponsor
- Lead sponsor
- Onze Lieve Vrouwe GasthuisAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 20, 2017
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A retrospective study will be performed to compare the incidence of revision procedures performed for the treatment of postoperative periprosthetic joint infection (PJI) between patients treated with a single preoperative antibiotic prophylaxis and patients treated with multiple shot antibiotic prophylaxis following primary arthroplasty of hip or knee. This study will be conducted in two phases. In phase 1 the investigators will evaluate which antibiotic prophylaxes (type of antibiotic and duration of prophylaxis) are regularly used in the Netherlands, by contacting all orthopaedic centres implanting total hip and total knee prostheses. In phase 2 the investigators will compare infection rate (defined as revision for infection as registered in the LROI database) between a single-shot and multiple shot antibiotic prophylaxis. Knee and hip primary arthroplasties will be considered separately.
Conditions
- Arthroplasty, Replacement, Hip
- Arthroplasty, Replacement, Knee
- Antibiotic Prophylaxis
Interventions
Single shot antibiotic prophylaxisDrug
single shot preoperative antibiotic prophylaxis
Multiple shot antibiotic prophylaxisDrug
Multiple shot perioperative antibiotic prophylaxis
Primary outcomes
What the sponsor says the trial is designed to measure.
- Revision arthroplasty because of infectionTime frame: one year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
OLVG
Amsterdam, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.